期刊文献+

喉部痰液胃蛋白酶浓度检测对喉咽反流诊断及疗效判定的价值 被引量:8

A study of the pepsin in the sputum for diagnosis and treatment evaluation of laryngopharyngeal reflux
原文传递
导出
摘要 目的:探讨喉部痰液胃蛋白酶检测对喉咽反流(LPR)诊断及其疗效判定的价值。方法:对2010-06-2010-07期间以咽干、咽喉部异物感、频繁清嗓、慢性咳嗽、发声易倦等症状就诊的36例患者进行3个月质子泵抑制剂诊断性治疗。治疗前后评估反流症状指数(RSI)、反流检查计分(RFS)及喉部痰液胃蛋白酶浓度。诊断性治疗有效者计入LPR组(15例),其余计入慢性咽炎组(21例),分析2组指标的差异和痰液胃蛋白酶检测的诊断价值。结果:所有患者RSI和RFS量表得分以及喉部痰液胃蛋白酶浓度在治疗后均有显著下降(均P<0.01)。LPR组RSI量表评分和胃蛋白酶浓度治疗前后的变化明显大于慢性咽炎组(均P<0.01);2组间RFS量表评分治疗前后的变化比较差异无统计学意义(P>0.05)。结论:喉部痰液胃蛋白酶浓度检测可以作为一项客观、有效的指标用于LPR的诊断和疗效判定。 Objective:To study the value of the pepsin in the sputum for diagnosing and evaluating the effectiveness of treatment of laryngopharyngeal reflux.Method:Thirty-six patients with the symptoms of dry pharynx,globus pharyngeus,excessive throat clearing,chronic cough and so on were divided into laryngopharyngeal reflux group and chronic laryngitis group by the results of therapeutic trial taking proton pump inhibitors for 3 months.The estimation of the reflux symptom index(RSI),the reflux finding score(RFS) and the detection of pepsin in the sputum were done before and after the treatment.The difference between two groups and the value of the pepsin were analyzed.Result:There were significant decreasing in RSI,RFS and pepsin level(P0.01)after the treatment in all patients.There were statistical differences between the laryngopharyngeal reflux group and the chronic laryngitis group in the changes of RSI and pepsin level(P0.01).Conclusion:Pepsin level in the sputum might be used as a objective,effective method for diagnosing and evaluating the effectiveness in laryngopharyngeal reflux.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第13期604-607,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 喉咽反流 胃蛋白酶 痰液 质子泵抑制剂 laryngopharyngeal reflux pepsin sputum proton pump inhibitor
  • 相关文献

参考文献16

  • 1POSTMA G N. Ambulatory pH monitoring methodol- ogy[J]. Ann Otol Rhinol Laryngol, 2000,184 : 10- 14.
  • 2BELAFSKY P C, POSTMA G N, KOUFMAN J A. Validity and reliability of the reflux symptom index (RSI) [J]. J Voice,2002,16:274-277.
  • 3BELAFSKY P C,POSTMA G N,KOUFMAN J A.The validity and reliability of the reflux finding score (RFS)[J]. Laryngoscope, 2001,111: 1313 - 1317.
  • 4KNIGHT J, LIVELY M O, JOHNSTON N, et al. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux [J]. Laryngoscope, 2005, 115:1473--1478.
  • 5李湘平,陈顺金,王路,刘雄,刘友利,曾芳芳.唾液中胃蛋白酶检测对咽喉反流的诊断价值[J].中华耳鼻咽喉头颈外科杂志,2009,44(2):99-104. 被引量:43
  • 6TAUBER S, MAILFMD G, ISSING W J. Association of laryngopharyngeal symptoms with gastroesophage al reflux disease[J]. Laryngoscope, 2002,112: 879- 886.
  • 7RICHTER J E, Extraesophageal presentations of gas- troesophageal reflux disease., an overviewEJ]. Am J Gastroenterol, 2000,95 : S1-S3.
  • 8TASKER A, DETTMAR P W, PANETTI M, et al. Is gastric reflux a cause of otitis media with effusion in children[J]? Laryngoscope, 2002,112 : 1930-- 1934.
  • 9FORD C N. Evaluation and management of hrynso- pharynseal reflux[J]. JAMA, 2005,294 : 1534- 1540.
  • 10JOHNSTON N, DELTMAR P W, BISHWOKARMA B, et al. Activity/stability of human pepsin: implica- tions for reflux attributed laryngeal disease[J]. La-ryngoscope,2007,117:1036-1039.

二级参考文献21

  • 1王晓晔,韩德民,叶京英.咽喉反流[J].国际耳鼻咽喉头颈外科杂志,2006,30(5):281-285. 被引量:46
  • 2Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA, 2005, 294: 1534-1540.
  • 3Karkos PD, Potamianos SP, Apostolidis MT, et al. When gastroenterology met otolaryngology: laryngopharyngeal reflux. Am J Med, 2006, 119: e19-20.
  • 4Salminen P, Sala E, Koskenvuo J, et al. Reflux laryngitis: a feasible indication for laparoscopic antireflux surgery? Surg Laparosc Endosc Percutan Tech, 2007, 17 : 73-78.
  • 5Koufman JA, Aviv JE, Casiano RR, et al. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology- Head and Neck Surgery. Otolaryngol Head Neck Surg, 2002, 127 : 32-35.
  • 6Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD) : a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope, 1991, 101 (4 Pt 2 Suppl 53 ) : 1-78.
  • 7Dunn BM. Structure and mechanism of the pepsin-like family of aspartic pcptidases. Chcm Rev, 2002, 102 : 4431-4458.
  • 8Adhami T, Goldblum JR, Richter JE, et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol, 2004, 99: 2098-2106.
  • 9Ishikawa T, Sekizawa SI, Sant'Ambrogio FB, et al. Larynx vs. esophagus as reflexogenic sites for acid-induced bronchoconstriction in dogs. J Appl Physiol, 1999, 86: 1226-1230.
  • 10Knight J, Lively MO, Johnston N, et al. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope, 2005, 115: 1473-1478.

共引文献42

同被引文献86

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部